There are 2867 resources available
LBA13 - Nivolumab and ipilimumab in early-stage triple negative breast cancer (TNBC) with tumor-infiltrating lymphocytes (TILs): First results from the BELLINI trial
Presenter: Marleen Kok
Session: Proffered Paper session: Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
Approach to inhibition of activating FGFR2 fusions
Presenter: Francesco Facchinetti
Session: Lessons learned and new horizons and other hepatobiliary/pancreatic malignancies
Resources:
Slides
Webcast
Therapeutic implications for gliomas
Presenter: Carmen Balana
Session: Insight the new CNS WHO classification: Novel concepts and therapeutic implications for gliomas
Resources:
Slides
Webcast
Plasticity: The door for tumour escape?
Presenter: Celine Vallot
Session: Is heterogeneity the limitation of precision oncology in melanoma?
Resources:
Slides
Webcast
New therapies and questions for EGFR, Exon 20 and HER2 mutation
Presenter: Zofia Piotrowska
Session: Slicing the pie: Advances in targeted therapy for oncogene-addicted NSCLC
Resources:
Slides
Webcast
Applying the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
Presenter: Joaquin Mateo
Session: Complex technologies for diagnosis: How do we implement and use them globally?
Resources:
Slides
Webcast
An ESMO framework for de-escalation of antineoplastic therapies: Principles and considerations
Presenter: Dario Trapani
Session: De-escalation of treatment in medical oncology
Resources:
Slides
Webcast
Physical activity and cancer
Presenter: Marianne Himberg
Session: Health promotion, prevention, and screening
Resources:
Slides
Webcast
657MO - Effectiveness of geriatric assessment-driven interventions on quality of life for 2 years in older patients with head and neck cancer: Results from the EGeSOR trial
Presenter: Charlotte Lafont
Session: Mini Oral session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
453O - DS-7300 (B7-H3 DXd antibody-drug conjugate [ADC]) shows durable antitumor activity in advanced solid tumors: Extended follow-up of a phase I/II study
Presenter: Toshihiko Doi
Session: Proffered Paper session: Developmental therapeutics
Resources:
Abstract
Slides
Webcast